Your choices go into the PDF (cover and captions); this bar does not.
Rebalix
Comparison report · official data side by side

CSPX vs INCI


CSPXiShares Core S&P 500 UCITS ETF
IE00B5BMR087 · Equity · United States · Large cap
INCIiShares U.S. Equity High Income Active UCITS ETF
IE0007FM00T9 · Equity · United States · Large & mid cap · Dividend
Open the interactive comparison on rebalix.com →

Comparison window: 22 Mar 202431 Aug 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared

Report produced on 4 September 2026 · data as of the dates shown per section
Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat
Public methodology: rebalix.com/en/methodology

Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.

RebalixCSPX vs INCI · report of 4 September 2026

The funds at a glance

From official issuer documents and the ESMA register
CSPXIE00B5BMR087iShares Core S&P 500 UCITS ETFEquity · United States · Large cap
Declared index
S&P 500 Index
TER
0.07%
Transaction (KID)
0.00%
Fund size
133.4 mld EUR
Launch
19 May 2010
Currency
USD
Replication
Physical
Hedging
No
Holdings
504
Effective 🇮🇹 rate
26.00%
INCIIE0007FM00T9iShares U.S. Equity High Income Active UCITS ETFEquity · United States · Large & mid cap · Dividend
Declared index
S&P 500 Index
TER
0.35%
Transaction (KID)
0.25%
Fund size
6 mln EUR
Launch
22 Mar 2024
Currency
USD
Replication
Gestione attiva (dal KID)
Hedging
No
Holdings
329
Effective 🇮🇹 rate
25.72%

Tracking difference — year by year

Fund minus index, from issuer-declared series (complete calendar years). Each measures adherence to its OWN index.
CSPX3y avg: +0.19%/anno
2025
+0.15%
2024
+0.18%
2023
+0.25%
2022
+0.17%
2021
+0.20%
2020
+0.26%
INCI3y avg: −1.18%/anno
2025
−3.54%
2024
+0.00%
2023
+0.00%
2022
+0.00%
2021
+0.00%
Rebalix · CSPX vs INCIsection 1 of 4
RebalixCSPX vs INCI · report of 4 September 2026
CSPXiShares Core S&P 500 UCITS ETF · IE00B5BMR087 · Equity · United States · Large cap
INCIiShares U.S. Equity High Income Active UCITS ETF · IE0007FM00T9 · Equity · United States · Large & mid cap · Dividend

Performance over the period, in euro

From 22 Mar 2024 to 31 Aug 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
10014393140135
In today’s purchasing power (net of Italy inflation)
10014393134129
CSPXINCI
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.

How far they fell — drawdown from peak (nominal)

In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
0%-5%-10%-15%-20%-25%-30%CSPXINCI20252026trough CSPX: −22.6% · 08 Apr 2025trough INCI: −21.1% · 08 Apr 2025
Filled area: CSPX; thin lines: the other funds.
The worst episode, fund by fund
FundMax drawdownTroughRecovery timeUnderwater
CSPX−22.6%08 Apr 2025199 days247 days · back to break-even on 24 Oct 2025
INCI−21.1%08 Apr 2025372 days420 days · back to break-even on 15 Apr 2026
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.

Drawdown net of Italy inflation

Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
0%-5%-10%-15%-20%-25%-30%CSPXINCI20252026trough CSPX: −24.1% · 08 Apr 2025trough INCI: −22.6% · 08 Apr 2025
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
Rebalix · CSPX vs INCIsection 2 of 4
RebalixCSPX vs INCI · report of 4 September 2026
CSPXiShares Core S&P 500 UCITS ETF · IE00B5BMR087 · Equity · United States · Large cap
INCIiShares U.S. Equity High Income Active UCITS ETF · IE0007FM00T9 · Equity · United States · Large & mid cap · Dividend

Geographic composition

% of portfolio, from full declared holdings
CSPXINCIUnited States100.1%96.6%United Kingdom0.0%0.0%Mexico0.0%0.0%European Union0.0%0.0%Ireland0.0%3.1%

Sector composition

GICS sectors, same sources and dates
CSPXINCIInformation Technology37.8%35.4%Financials12.3%11.7%Communication9.5%9.6%Health Care9.3%9.7%Consumer Discretionary9.1%8.8%Industrials8.3%6.6%Consumer Staples4.5%5.8%Energy3.5%3.9%

Portfolio overlap

213 common holdings · ticker match on full official portfolios
25%50%75%100%Weight of common holdings in CSPX81.7%Weight of common holdings in INCI91.2%Truly shared part (duplicated investment)71.4%
How the shared part is computed: for each security held by both funds, only the SMALLER of the two weights counts — a stock at 5% in one fund and 1% in the other overlaps by 1%, not 5%. Summed over all 213 common holdings this gives 71.4%: buying both funds, roughly this share of your money buys the same stocks twice.
Rebalix · CSPX vs INCIsection 3 of 4
RebalixCSPX vs INCI · report of 4 September 2026

Full comparison table

"—" = not published by the source, never estimated
CSPXiShares Core S&P 500 UCITS ETF · IE00B5BMR087 · Equity · United States · Large cap
INCIiShares U.S. Equity High Income Active UCITS ETF · IE0007FM00T9 · Equity · United States · Large & mid cap · Dividend
MetricCSPXINCINote
Identity
CategoryEquity · United States · Large capEquity · United States · Large & mid cap · DividendRebalix engine classification
ReplicationPhysicalGestione attiva (dal KID)as declared by the issuer
Currency hedgingNoNosource: class name, factsheet
Income policyaccumulatingaccumulating
Costs
TER0.07%0.35%from the KID
Transaction costs (KID)0.00%0.25%internal
All-in cost0.07%0.60%TER + transaction
Tracking difference (3a)+0.19%−1.18%vs its OWN index
Performance in euro (ECB rates)
1 year+20.7%+20.9%
3 years+64.9%
5 years+83.2%
10 years+289.6%— = series younger than the window
Risk · last 3 years
Volatility (ann.)+14.84%
Max drawdown−18.78%
Sharpe1.14risk-free = ECB MRO avg
Sortino1.67like Sharpe, downside only
Italian taxation
Effective capital-gains rate26.00%25.72%white list, current half-year
Documents & exchanges
Listing venues105ESMA register
Borsa Italiana tickerCSSPXINCI
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~45 euro CSPX · ~378 euro INCI. Broker costs not included.

Disclaimer

This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.

Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.

Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.

Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.

Rebalix · CSPX vs INCIsection 4 of 4